NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, announced the launch of Software-Enhanced Drug™ therapies, part of ...
FDA’s recent draft guidance, Regulatory Considerations for Prescription Drug Use Related Software, proposes a regulatory framework for software disseminated by a drug sponsor that supplements or ...
In late September 2023, the U.S. Food and Drug Administration (FDA) released a draft guidance on “Regulatory Considerations for Prescription Drug Use-Related Software.” This guidance expands on (and ...
Boston and San Francisco-based Pear Therapeutics, not to be confused with Pear Sports, has raised an undisclosed sum in a round led by 5AM Ventures. The company has developed a product called ...
“Soon, each drug could have a ‘smart’ dosage that combines a highly validated, fully digital therapeutic with traditional pharmacotherapy – a software-enhanced drug,” said Han Chiu, chief technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results